Skip to main content
. 2024 Sep 3;11:1438798. doi: 10.3389/fcvm.2024.1438798

Table 3.

Outcomes of patients.

Outcomes Intervention group (N = 619) Control group (N = 619) P
Primary outcome
28-day mortality, no. (%) 133 (21.5) 168 (27.1) 0.020
Secondary outcomes
LOS [median (IQR)], days
 In ICU 5.92 [3.64, 10.92] 5.04 [3.23, 9.23] 0.001
 In hospital 12.36 [7.86, 20.46] 11.29 [6.81, 18.62] 0.018
28-day cumulative mechanical ventilation–free days [median (IQR)], days 26.23 [22.23, 27.54] 26.60 [23.42, 28.00] 0.002
28-day cumulative vasoactive agent–free days [median (IQR)], days 26.75 [24.95, 27.56] 26.10 [24.30, 27.17] <0.001
28-day cumulative RRT–free days [median (IQR)], days 28.00 [28.00, 28.00] 28.00 [28.00, 28.00] 0.685

Data are presented as mean ± SD or median (interquartile range) for skewed variables or proportions for categorical variables.

LOS, length of stay; IQR, interquartile range; ICU, intensive care unit; RRT, renal replacement therapy.